Skip to content
Open Data Finder
Open Government Canada

Notice of clarification to drug manufacturers and sponsors - Risk Management Plans - Update

Published by Health Canada | Santé Canada

About this dataset

This notice is being issued to clarify to drug manufacturers and sponsors that elements of Risk Management Plans (RMPs) required by Health Canada, such as controlled distribution programs, are not intended to restrict access to Canadian Reference Products (CRPs) for generic drug manufacturers for the purposes of conducting comparative testing.

Notice of clarification to drug manufacturers and sponsors - Risk Management Plans - Up… · Open Data Finder